Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 Inflammasome Signalling pathway

BACKGROUND: Cerebral ischemia is the second-leading cause of death and the main cause of permanent adult disabilities worldwide. Qingkailing (QKL) injection, a patented Chinese medicine approved by the China Food and Drug Administration, has been widely used in clinical practice to treat cerebral is...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Chongyang, Wang, Xueqian, Xu, Tian, Yu, Xue, Zhang, Shuang, Liu, Shuling, Gao, Yushan, Fan, Shuning, Li, Changxiang, Zhai, Changming, Cheng, Fafeng, Wang, Qingguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868863/
https://www.ncbi.nlm.nih.gov/pubmed/31747940
http://dx.doi.org/10.1186/s12906-019-2703-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868863/
https://www.ncbi.nlm.nih.gov/pubmed/31747940
http://dx.doi.org/10.1186/s12906-019-2703-5

Ejemplares similares